Vitamin K2 Market by Source and Geography - Forecast and Analysis 2022-2026

The vitamin K2 market share is expected to increase by USD 92.34 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 8.92%.

This vitamin K2 market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers vitamin K2 market segmentation by source (natural and synthetic) and geography (North America, Europe, Asia, and ROW). The vitamin K2 market report also offers information on several market vendors, including Anderson Global Group LLC, Kappa Ingredients GmbH, Koninklijke DSM NV, Lesaffre and Cie, MENADIONA SL, Nakoda Chemicals Ltd., Purayati, Seebio Biotech (Shanghai) Co. Ltd., Viridis BioPharma Pvt. Ltd., and Vox Nutrition Inc. among others.

What will the Vitamin K2 Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Vitamin K2 Market Size for the Forecast Period and Other Important Statistics

 

Vitamin K2 Market: Key Drivers and Trends

The increasing demand for vitamin supplements is notably driving the vitamin K2 market growth, although factors such as strict government regulations on supplement endorsement and testing may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the vitamin K2 industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Vitamin K2 Market Driver

One of the key factors driving growth in the vitamin K2 market is the increasing demand for vitamin supplements. The number of cases of vitamin deficiency has been steadily growing in recent years. The rising prevalence of vitamin deficiency illnesses is driving the demand for vitamin-containing nutraceuticals. For instance, vitamin K deficiency bleeding (VKDB) is a disorder in which newborns are unable to stop bleeding because their blood lacks enough Vitamin K to form a clot. Healthcare experts and CDC classify VKDB into three categories, namely: early, classical, and late. Early and classical VKDB is more common, affecting 1 in 60 to 1 in 250 newborns, but late VKDB is rare, affecting 1 in 14,000 to 1 in 25,000 children. Factors such as this will propel the market toward positive growth during the forecast period.

Key Vitamin K2 Market Challenge

The strict government regulations on supplement endorsement and testing will be a major challenge for the vitamin K2 market during the forecast period. To satisfy the criteria set by governments, key companies in the vitamin K2 market must follow the laws and regulations established by them. Controlling permits, establishing regulations for new entrants, residual management concerns, and inspecting expiry dates for specific items, such as nutritional supplements, are under the purview of relevant authorities. The FDA is in charge of regulating the production and distribution of functional foods and nutraceuticals in the US. If certain rules regarding ingredients use, dosage and procedure are not followed, the product will either be abandoned or will not be introduced into the market, which, in turn, will restrict the market growth.

This vitamin K2 market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Who are the Major Vitamin K2 Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

• Anderson Global Group LLC
• Kappa Ingredients GmbH
• Koninklijke DSM NV
• Lesaffre and Cie
• MENADIONA SL
• Nakoda Chemicals Ltd.
• Purayati
• Seebio Biotech (Shanghai) Co. Ltd.
• Viridis BioPharma Pvt. Ltd.
• Vox Nutrition Inc.

 

This statistical study of the vitamin K2 market encompasses successful business strategies deployed by the key vendors. The vitamin K2 market is fragmented and the vendors are deploying growth strategies such as forming strategic partnerships to compete in the market.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The vitamin K2 market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

Which are the Key Regions for Vitamin K2 Market?

For more insights on the market share of various regions Request for a FREE sample now!

38% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for vitamin K2 in North America. Market growth in this region will be slower than the growth of the market in the European and Asian regions.

The expanding use of herbal medicines, increased consumer attention on health and wellbeing, rising healthcare expenditures, and increased demand for vitamin supplements, food and beverage, and cosmetic sectors will facilitate the vitamin K2 market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

What are the Revenue-generating Source Segments in the Vitamin K2 Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The vitamin K2 market share growth by the natural segment will be significant during the forecast period.

This report provides an accurate prediction of the contribution of all the segments to the growth of the vitamin K2 market size and actionable market insights on post COVID-19 impact on each segment.

 

Vitamin K2 Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 8.92%
Market growth 2022-2026	$ 92.34 million
Market structure	Fragmented
YoY growth (%)	6.09
Regional analysis	North America, Europe, Asia, and ROW
Performing market contribution	North America at 38%
Key consumer countries	US, Canada, Germany, China, and UK
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	Anderson Global Group LLC, Kappa Ingredients GmbH, Koninklijke DSM NV, Lesaffre and Cie, MENADIONA SL, Nakoda Chemicals Ltd., Purayati, Seebio Biotech (Shanghai) Co. Ltd., Viridis BioPharma Pvt. Ltd., and Vox Nutrition Inc.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Vitamin K2 Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive vitamin K2 market growth during the next five years
• Precise estimation of the vitamin K2 market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the vitamin K2 industry across North America, Europe, Asia, and ROW
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of vitamin K2 market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch